依达拉奉治疗急性缺血性脑卒中临床疗效观察

[目的]探讨依达拉奉治疗急性缺血性脑卒中患者的临床疗效。[方法]将某院2008年6月～2010年6月的60例神经内科住院急性缺血性脑卒中患者随机分为治疗组与对照组各30例,治疗组应用依达拉奉治疗并与对照组进行神经功能评分、梗死面积、临床疗效的比较。[结果]治疗组的总有效率为90%,对照组的总有效率为66.7%,差异有统计学意义(P﹤0.05);治疗组的神经功能缺损评分与对照组差异有统计学意义(P﹤0.05);治疗组和对照组的梗死面积分别缩小差异有统计学意义(P﹤0.05)。[结论]运用依达拉奉治疗急性缺血性脑卒中有较好的临床疗效。

THE CLINICAL OBSERVATION OF THE EFFECT OF EDARAVONE FOR ACUTE ISCHEMIC STROKE

[Objective]To investigate the clinical efficacy for edaravone treatment of patients with acute ischemic stroke.[Methods]60 acute ischemic stroke patients in the department of neurology of our hospital from June 2008 to June 2010 were randomly divided into the treatment group with 30 cases and the control group with 30 patients.The treatment group was taken with edaravone treatment and compared with the control group about neurological score,infarct size and clinical efficacy.[Results]The total effective rate of the treatment group was 90%.The total effective rate in the control group was 66.7%,the difference was statistically significant(P﹤0.05).The difference of the neurological deficit scores in the treatment group and control group were statistically significant(P﹤0.05).The differences of the reducing infarct size in the two groups were statistically significant(P﹤0.05).[Conclusion]The application of edaravone treatment for acute ischemic stroke has better clinical efficacy.